Reason |
Number of studies |
Sanofi is not the sponsor or does not have legal right to share
|
25 |
Product development ongoing
|
6
|
Product with ongoing regulatory activities
|
14
|
Requested data not patient-level data or clinical documents |
3
|
Requested data not collected in English |
2
|
Requested information already publicly available |
2
|
High risk of re-identification |
37
|
Study not completed or not yet accepted for publication |
5
|
Data not available due to the age of the study |
1
|
Patent/ Litigation related reason |
9
|
Competes with sponsor's publication plan
|
2
|
Not compatible with ICF
|
1
|
Proposal number
|
Study Sponsor(s)/funder(s)
|
Reason(s)
|
615 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
618 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
633 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
690 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
931 |
BI/GSK |
The Research Proposal did not meet the Sponsor
policies for informed consent |
938 |
BI/GSK/Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
941 |
Roche |
The Research Proposal is not seeking access to
anonymised patient level data |
1047 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1087 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1107 |
GSK |
The Research Proposal is not seeking access to
anonymised patient level data |
1552 |
Novartis |
The proposed research required data that was not collected in the studies requested |
1235 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
1245 |
BI |
The Research Proposal competes with the Sponsor's publication plan |
1589 |
Novartis |
The Research Proposal is not seeking access to anonymised patient level data |